44% earnings growth over 1 year has not materialized into gains for Ship Healthcare Holdings (TSE:3360) shareholders over that period

Investors can approximate the average market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realized by Ship Healthcare Holdings, Inc. (TSE:3360) shareholders over the last year, as the share price declined 23%. That's disappointing when you consider the market returned 4.3%. Longer term shareholders haven't suffered as badly, since the stock is down a comparatively less painful 16% in three years. Shareholders have had an even rougher run lately, with the share price down 11% in the last 90 days.

If the past week is anything to go by, investor sentiment for Ship Healthcare Holdings isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

We check all companies for important risks. See what we found for Ship Healthcare Holdings in our free report.

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During the unfortunate twelve months during which the Ship Healthcare Holdings share price fell, it actually saw its earnings per share (EPS) improve by 44%. It could be that the share price was previously over-hyped.

It's surprising to see the share price fall so much, despite the improved EPS. So it's easy to justify a look at some other metrics.

Ship Healthcare Holdings managed to grow revenue over the last year, which is usually a real positive. Since the fundamental metrics don't readily explain the share price drop, there might be an opportunity if the market has overreacted.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

We know that Ship Healthcare Holdings has improved its bottom line lately, but what does the future have in store? If you are thinking of buying or selling Ship Healthcare Holdings stock, you should check out this free report showing analyst profit forecasts.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Ship Healthcare Holdings the TSR over the last 1 year was -21%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

While the broader market gained around 4.3% in the last year, Ship Healthcare Holdings shareholders lost 21% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 3% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Before forming an opinion on Ship Healthcare Holdings you might want to consider these 3 valuation metrics.

Of course Ship Healthcare Holdings may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Japanese exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.